Low Institute for Therapeutics Email Formats
Biotechnology Research • 
West Lafayette, Indiana, United States • 1-10 Employees
Key Contacts at Low Institute for Therapeutics
Stewart Low
Executive Director
Mary Niedrauer
Sr. Director, Nonclinical And Cmc
Company overview
| Headquarters | West Lafayette, Indiana, United States |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About Low Institute for Therapeutics
The Low Institute for Therapeutics is a nonprofit research organization established to reduce human suffering from disease based on the pioneering work of Dr. Philip Low, Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. The Low Institute is focused on advancing clinical studies of innovative medicines designed to precisely treat a wide range of diseases by preferentially targeting diseased tissue, thereby improving efficacy, reducing side effects and improving patient outcomes. The institute is focused on diseases which significantly impact human health, including malaria, many types of cancer, chronic kidney disease, pulmonary fibrosis, heart failure, rheumatoid arthritis, organ transplant rejection, fatty liver disease, Alzheimer’s disease, sickle cell anemia and bone fractures.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Low Institute for Therapeutics has 4 employees across 2 departments.
Departments
Number of employees
Funding Data
Low Institute for Therapeutics has never raised funding before.
Austria
Philippines
United Kingdom
China
Switzerland
Spain
IndiaFrequently asked questions
4.8
40,000 users
